|
HS Code |
771744 |
| Product Name | Pyrrosiae Folium Veterinary Grade API |
| Synonyms | Pyrrosia Leaf Extract |
| Formulations | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Intended Use | Veterinary pharmaceutical preparations |
| Main Component | Pyrrosia sheareri leaf extract |
| Appearance | Brownish powder |
| Solubility | Partially soluble in water |
| Storage Conditions | Cool, dry place away from direct sunlight |
| Shelf Life | 24 months when properly stored |
| Api Purity | ≥98% |
| Source | Natural botanical extract |
| Standard Compliance | Veterinary GMP |
| Manufacturer Country | China |
| Usage | Supplements for animal urinary and respiratory health |
As an accredited Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed 25 kg fiber drum with double-layer polyethylene inner bag, clearly labeled for Pyrrosiae Folium Veterinary Grade API, suitable for multiple formulations. |
| Shipping | The Pyrrosiae Folium Veterinary Grade API is securely packaged in fiber drums with double polyethylene bags, ensuring protection from moisture and contamination. Shipping is available by air, sea, or express courier, with prompt delivery and complete documentation, meeting international safety and quality transport standards for tablets, injections, capsules, powders, granules, premix, and solutions. |
| Storage | Pyrrosiae Folium Veterinary Grade API should be stored in a tightly sealed container, protected from light, moisture, and excessive heat. Keep in a cool, dry, and well-ventilated area, away from incompatible substances. Ensure that the storage environment is clean and free from contaminants to maintain the product's potency, stability, and safety for tableting, injection, capsule, powder, granule, premix, and solution formulations. |
|
Purity 99%: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions of Purity 99% is used in oral medication formulations for livestock, where it ensures superior efficacy and reduces the risk of contamination. Particle Size ≤80 mesh: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Particle Size ≤80 mesh is used in premix animal feeds, where it promotes uniform blending and optimal bioavailability. Moisture Content ≤5%: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions having Moisture Content ≤5% is used in powder formulations, where it enhances product stability and prevents microbial growth. Stability Temperature up to 40°C: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Stability Temperature up to 40°C is used in storage and transportation under varied climates, where it maintains consistent potency and shelf-life. Extract Ratio 10:1: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions at Extract Ratio 10:1 is used in injection preparations for veterinary clinical use, where it delivers concentrated active constituents for rapid therapeutic action. Heavy Metal Content ≤10ppm: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Heavy Metal Content ≤10ppm is used in capsule manufacturing, where it ensures safety according to international regulatory standards. Assay ≥95% Active Ingredient: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Assay ≥95% Active Ingredient is used in injectable formulations, where it assures reliable dosing and predictable pharmacological outcomes. Solubility in Water >90%: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Solubility in Water >90% is used in solution-based veterinary medicines, where it supports rapid dissolution and absorption in animal systems. Loss on Drying ≤3%: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Loss on Drying ≤3% is used in granule and premix applications, where it helps preserve ingredient integrity and prolongs product durability. Microbial Limit ≤1000cfu/g: Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Microbial Limit ≤1000cfu/g is used in powder supplements for young animals, where it minimizes microbial contamination and maintains animal health. |
Competitive Pyrrosiae Folium Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Over the past decades, the veterinary health sector has grown to appreciate the unique benefits that herbal actives can bring when integrated into modern dosage forms. Pyrrosiae Folium, sourced from established agricultural bases and processed under pharmaceutical-grade standards, represents one such botanical that our facility has focused on for ongoing development and supply. Our hands never leave the quality chain, from green leaf to finished active ingredient. Years of refining the manufacturing process have taught us that consistency in raw materials and attention to extraction parameters directly affect the performance of every batch we produce. It is not enough to grow the plant; our business involves guiding the entire journey from soil to medicine, ensuring veterinary practitioners can depend on reproducible results.
Veterinary medicine often requires flexibility. Each species, each dosage form, puts forth unique challenges. Veterinarians call for APIs that can move seamlessly from a high-precision tablet into a flowing, homogenous premix or soluble solution. We understand this because we have walked the entire process ourselves, scaling up from pilot-size experiments to tonnage production. Whether the target is a robust bolus for large ruminants or a fine dispersible powder for inclusion in feed or water, our team adapted the processing for the physical and chemical properties of Pyrrosiae Folium. As a veteran manufacturer, our experience told us not to treat all grades as interchangeable. More than once, we heard from customers about issues mixing other sources into capsules or finding that certain leaf powders sluggishly disperse in solution. Those problems drive our daily work. Each form—finely milled powder, concentrated granule, high-purity extract for injection, optimized blend for premix—undergoes its own quality and performance testing before it ever enters a customer’s system.
Some might still wonder, how different can an herbal API truly be? Industry wisdom and feedback from the field prove that with Pyrrosiae Folium, the devil is in the details. Sourcing only certified fields with traceable planting history helps control for pesticide residue, heavy metals, and the variability that often plagues herbal supply chains. Our model, built around repeated batch analysis and full-lot retention samples, guards against surprises. We also prioritize actives standardization, maintaining marker compounds within tightly controlled limits in every specification sheet, not merely as a formality, but as a foundation for veterinary dosing, no matter the product format.
Our technical teams work constantly with feed millers, formulation chemists, and practicing veterinarians who expect more than a letterhead guarantee. Consider the demands of injectable solutions: low-endotoxin standards, microbiological clearance, a particle-free finish. We addressed these by investing in precision filtration, sterile blending, and sealed handling systems—steps that don’t always show up in paperwork, but do reveal themselves in clinic shelf stability and low batch-to-batch variation. For solid dose products like tablets or capsules, we honed micronization protocols to match target particle size distributions that enable even compaction and flow. Feed millers, in particular, notice the difference during process runs, especially at high-speed dosage and mixing lines.
Our strict specification ranges for veterinary grade Pyrrosiae Folium go far beyond color and odor checks. Experienced operators in our extraction hall know that precise control of moisture, ash, and solvent residue count for more in practice than on paper. We target a particle size suitable for each application—no oversized ‘fluff’ to gum up feeders, no chalky fines to prompt dust or caking complaints in finished feeds. For injection-grade material, we invest in further purification, ensuring not just purity but safety at the cellular level, reflected in clinical tolerability. These standards have been built based on what works in animal hospitals, feed plants, and at farm level, not only by the requirements of a remote specification document.
Pyrrosiae Folium, an herb long used in traditional veterinary medicine, has drawn increasing interest within integrative practice over the last fifteen years. Studies and clinical reports highlight its role in diuretic, anti-inflammatory, and respiratory applications primarily among livestock and companion animals. Seeing the potential early on, our team invested in scaled procurement and vertical integration, building expertise in both the agricultural and extraction aspects. Through on-site visits, regular field audits, and continuous training for our raw material partners, we reduced the season-to-season swing in active markers, setting a new reliability benchmark for a once-variable ingredient.
The transition of Pyrrosiae Folium from field remedy to registered veterinary functional ingredient involved not just regulatory diligence but a clear focus on how to deliver reproducible dosing in modern animal health products. Our R&D specialists continue to work with veterinary universities, adapting extraction protocols and innovating new formulations so that the plant’s beneficial components withstand industrial processing and remain available at the point of dosing.
Real life in the veterinary world rarely follows a template. A capsule needs different attributes than a bulk feed additive. Injections for small animals cannot tolerate the same levels of particulate or bioburden as a premix for cattle rations. Every week, our team convenes with veterinarians and finished product facilities to review performance feedback and emerging needs. For tablet makers, we ship material specified for compressibility, flow expectation, and content uniformity, knowing that automated dosing and low wastage are critical at scale. Premix manufacturers have shown us first-hand how fluidity, resistance to caking, and ease of handling make or break a formula’s usefulness.
Over the years, this feedback loop led us to fine-tune product lines not just by analysis sheet but by in-factory performance. Pyrrosiae Folium for injection undergoes even finer screening for microbiological safety and extract clarity than those designed for oral dosing. Powders for direct addition to feed receive anti-caking treatments only after confirming compatibility by ongoing stability trials, never simply out of habit. Each time we add a new product form, we run trial batches under the same stress conditions our users describe—high humidity, variable temperatures, large volume feed mixing, or high-volume oral drug manufacturing lines. Our process does not end until the ingredient proves stable, easy to dose, and reaches the intended animals in its active form.
Few things frustrate veterinary practitioners more than unresolved quality issues in herbal APIs. Too much microbiological load can force batch disposal or expensive rework. Inconsistent marker content leads to confusion about dose, undermines clinical trials, or causes regulatory pushback. We have faced these obstacles by inviting third-party laboratories and academic partners to evaluate our processes and deliver actionable scrutiny. This approach produced improvements we could never achieve in isolation—better screening before procurement, route-to-route analysis of extract stability, and even modifications of drying protocols to boost actives without raising residual solvent problems. Our technical managers spent months refining extract concentration and drying curves, learning that slow temperature ramping preserves active saponins best, while high-velocity airflow minimizes unwanted degradation of secondary metabolites.
Reports of variable batch flow and lumping in other producers’ powders prompted us to launch a series of long-term handling studies in real-world feed plants and compounding labs. By sending technical teams to customer sites, we gained practical insight into how subtle adjustments in granule moisture or surface treatment could save hours of clean-up or even prevent costly line downtime. Results from these collaborations led to refinements in our processing line, like inline granulation checks and multi-stage milling, rather than simple bulk reduction. We urge every partner to audit us and we share full traceability records, including origin, processing logs, and product certificates, for every lot delivered.
Years ago, market feedback made it clear that a one-size-fits-all approach to Pyrrosiae Folium left too many problems unsolved. Poultry operations required dispersible powders that could blend swiftly and resist sedimentation, while swine operations prioritized formulations to avoid dustiness and cross-contamination. Tablet makers often told us that standard extract or powder behaved unpredictably under compression, leading to variable absorption and tablet hardness. Rather than force one form into every process, we shifted to a modular production system.
For tablets and capsules, we prepare a micronized grade, using controlled particle size reduction with high-energy milling equipment. This grade reaches a tight distribution around the target range, allowing even granule mixing and predictable press performance. For injection and solution forms, the extraction step adds layers of filtration and purification followed by solvent removal in carefully monitored vacuum ovens. Powders for feed applications often undergo a final anti-caking step and moisture adjustment, making them practical for daily farm operations without compromising stability.
Through years of troubleshooting alongside formulators and veterinarians, our offering expanded from plain raw powders to cover semi-finished concentrates, carriers, and blends that line up with regulatory requirements and overcome documented field problems like settling, incomplete suspension, or offline quality rejections. Rather than offer abstract "solutions," we work case-by-case, aligning the process to specific feedback from clinics, mills, and finished dosage plants. Every variant starts and ends with customer performance in mind, not manufacturing convenience.
The herbal veterinary ingredients landscape can be confusing, with cut corners and overlapping terms clouding genuine distinctions. Not every Pyrrosiae Folium powder on the market meets the same standards, nor do all conform to the requirements of veterinary dosage development. Some sellers blend crude leaf powder, label it as "veterinary grade," yet skip any meaningful processing or full-range analysis. Those products enter feed lines but bring unpredictable active content, trace contaminants, and challenges for dosing accuracy and safety.
Our manufacturing ethos opposes these shortcuts. The processes that define good pharmaceutical APIs—regular marker compound analysis, controlled drying, purification, safe extraction solvents, and ongoing stability and residue checks—are non-negotiable for us. In every batch, both raw material and finished product samples undergo screening. If a supplier cannot deliver consistent certificate traceability, they do not enter our chain. End-users, from farm managers to veterinary hospitals, notice these differences, even though they might not always have the technical means to verify them on entry. That’s why we emphasize site visits and post-market surveillance, sending our staff into the field to see first-hand how the ingredient performs across a range of uses.
Being a direct manufacturer, not a broker or paperwork-driven intermediary, changes the daily work. We keep our team close to the manufacturing floor, with supervisors spending time on every shift and technical managers carrying responsibility from procurement through to finished lot release. Our batch records, cleaning logs, and deviation reports flow directly into ongoing improvement meetings each week. Having full-site control allowed us to adapt process schedules to customer lead times and offer rush production in case of veterinary emergencies—a flexibility that resellers simply cannot provide.
In the last five years, we coordinated directly with global animal health partners to launch multi-site usage studies. Feedback led to multiple rounds of process refinement: optimizing extraction solvents, eliminating post-drying dust, automating more steps to reduce handling-related error, and setting stricter internal residual solvent targets than those visible on outgoing specs. The dialogue also produced specialized lots for early-phase trials and orphan species, building new data for future product registrations.
Ask veterinarians who work with a range of herbal APIs about the visible distinctions and the same three points reappear: purity, handling, and real-life bioavailability. Our Pyrrosiae Folium draws a line based on these fundamentals, shaped by hands-on feedback from clinics, feed mills, and compounding pharmacies. Resellers or passive intermediaries rarely invest in the end-to-end chain or in the technical support to resolve issues at source.
Our direct investments in in-house testing, in-line process monitoring, and third-party stability trials anchor the ingredients we supply. For veterinary hospitals, that means injectables arrive with the clarity, sterility, and bioactive content they require. For mass manufacturers of powder and granule feeds, shipments come without the settling and caking complaints that have historically dogged herb-based premixes. The difference becomes clear in product recalls—ours track back to a single facility, with full release documentation, not multi-stop traders whose records collapse at the first problem.
From our founding, we chose to invest in an integrated system rather than rely on bulk trading or on-again, off-again feed contracts. We committed resources to every rung of the production chain—agronomic best practices, targeted harvest timing, rapid post-harvest transport, clinical-grade extraction, multi-stage drying and granulation, plus ongoing validation studies with animal health partners. We listen not only to technical feedback, but also to the day-to-day realities of those using our APIs in the field: veterinarians prescribing, millers blending, and farm leaders evaluating animal recovery and feed consistency.
We consider our Pyrrosiae Folium Veterinary Grade API not just as a product, but as a platform for advancing herbal veterinary science. Our customers teach us that shortcuts in sourcing or manufacturing echo through the supply chain with outcomes ranging from dose irregularity to clinical failure. On the other hand, sustained partnerships, rigorous internal standards, and open data exchange can build trust batch after batch, ultimately delivering healthier, more predictable outcomes for every animal treated.